Share/Refer CSATC

Doctor Administers medical Marijuana

Keeping You Informed

CSATC - New Jersey Medical Marijuana Dispensary

News

Category: News

Qualifying Condition: Intractable Skeletal Muscular Spasticity

Muscle-Postier

Among the 14 qualifying conditions that allow New Jersey residents to register for the Medical Marijuana Program is Intractable Skeletal Muscular Spasticity.

Spasticity is caused by an imbalance of signals from the central nervous system to the muscles. This neurological condition is most often related to disorders like multiple sclerosis, cerebral palsy, traumatic brain injury, stroke, spinal injury and other conditions that harm parts of the nervous system.

This disorder presents symptoms mostly in skeletal muscles including involuntary overactive reflexes and movements, which may include spasms (brisk and/or sustained involuntary muscle contraction) and clonus (series of fast involuntary contractions), increased muscle tone, muscle stiffness and the inability to stretch the affected muscles.

 

In one of the largest studies conducted regarding cannabinoids and the treatment of spasticity, it showed evidence of improvements regarding patient-reported spasticity and pain, suggesting the
clinical usefulness of cannabinoids.

Other symptoms include contractures (a state of permanent contraction of a muscle /tendon due to severe and repetitive stiffness and spasms), decreased functional abilities, difficulty with care or hygiene, bone and joint deformities, abnormal posture and pain.

The pain a patient can experience from this condition can range from mildly stiff muscles to painful spasms in extremities, particularly one’s legs. Pain may also be present in a patient’s lower back or as pain or tightness around their joints.

In one of the largest studies conducted regarding cannabinoids and the treatment of spasticity, it showed evidence of improvements regarding patient-reported spasticity and pain, suggesting the clinical usefulness of cannabinoids.

According to MarijuanaDoctors.com, an Oxford study corroborated that medical cannabis could decrease muscle spasticity and pain. Other notable findings in the study were that the side effects of cannabis-based medicine had been predictable and tolerable, and the loss of bladder control was alleviated by cannabis extracts.

Similar findings were found in a review of multiple studies, which stated that a wealth of anecdotal studies show that cannabis and cannabinoids have “beneficial effects on disease-related pain, bladder symptoms, tremor and particularly spasticity, but until recently, little scientific evidence existed for their efficacy.”

Posted on in category: News, Qualifying Conditions | Tagged , , , | Comments Off

National Academy of Sciences Acknowledges Medicinal Benefits of Cannabis

CannabisCoverFinalOn January 12, 2017 The National Academies of Sciences, Engineering and Medicine published one of the most comprehensive reports of recent research regarding the health effects of cannabis. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research produced nearly 100 conclusions based off scientific evidence, and in certain cases finding “conclusive or substantial evidence” of the therapeutic effects of cannabis. At the top of the list, the study found conclusive or substantial evidence that cannabinoids are effective for the treatment of chronic pain in adults. Chronic pain is a qualifying condition for New Jersey’s Medical Marijuana Program only if it’s a symptom of cancer or HIV/AIDS.

Although chronic pain is currently limited to these restrictions, chronic pain, osteoarthritis, lupus and Lyme disease are of the 45 conditions that the Medicinal Medical Review Panel is set to consider as additional qualifying conditions.

Other conditions that the Academies’ report found cannabis effective for are chemotherapy-induced nausea/vomiting and improving patient reported multiple sclerosis spasticity symptoms.

The report also found moderate evidence of effective cannabinoid treatment for improving short-term sleep outcomes related to sleep apnea syndrome, fibromyalgia and multiple sclerosis. Limited evidence showed cannabinoids to be effective for improving symptoms of Tourette syndrome, symptoms of anxiety and symptoms of post traumatic stress disorder.

In terms of cancer, the report showed evidence suggesting that cannabis smoke doesn’t increase the risk for cancers that are often associated with tobacco use.

The National Academies are private, nonprofit institutions that provide objective guidance for policy makers through scientific evidence.

The issue of cannabis and health has been brushed aside by the National Academies since 1999, but substantial effort was put into this report with over 10,000 scientific abstracts reviewed in preparation.

Acknowledgements were made in the report that potential harm from cannabis may be noted related to risks for adolescents, pregnant women and those who operate motor vehicles shortly after ingesting cannabis. National Organization for the Reform of Marijuana Laws (NORML) says, “In each of these cases, these risks may be mitigated via marijuana regulation and the imposition of age restrictions in the marketplace.”

The committee that authored the report recommended more research to be done on the beneficial and harmful effects of cannabis, and emphasized the drug’s classification as a Schedule I substance being a barrier impeding such research.

Posted on in category: News, Research, Science | Tagged , , | Comments Off

Welcome

Welcome to Compassionate Sciences Alternative Treatment Center News. Our goal is to keep you informed about Cannabis-based therapies and how they can mitigate disease symptoms and offer a natural alternative to powerful pharmaceutical drugs that have debilitating side-effects. You may also signup to receive our RSS feed and get email alerts about our progress and to subscribe to our eNewsletter to stay connected to our news and updates.

Posted on in category: News | 1 Comment
Top